Galenica AG (LON: 0ROG)
London
· Delayed Price · Currency is GBP · Price in CHF
81.45
+0.13 (0.17%)
Jan 31, 2025, 4:17 PM BST
Galenica AG Revenue
Galenica AG had revenue of 1.91B CHF in the half year ending June 30, 2024, with 8.20% growth. This brings the company's revenue in the last twelve months to 3.80B, up 2.99% year-over-year. In the year 2023, Galenica AG had annual revenue of 3.76B with 4.47% growth.
Revenue (ttm)
3.80B CHF
Revenue Growth
+2.99%
P/S Ratio
n/a
Revenue / Employee
481.28K CHF
Employees
7,902
Market Cap
3.59B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
Dec 31, 2019 | 3.31B | 134.90M | 4.25% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |